CHARLOTTE CARLSON: Open Payments
NPI 1598056426 · SIGNAL HILL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,243 in 83 payments from 18 companies in 2025. Trend: 2023 $6,459 · 2024 $2,644 · 2025 $2,243
Food & beverage: $2,058Education: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $365 |
| GENZYME CORPORATION | 9 | $337 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $328 |
| Amgen Inc. | 10 | $188 |
| PFIZER INC. | 11 | $187 |
| Janssen Biotech, Inc. | 8 | $183 |
| Lilly USA, LLC | 6 | $144 |
| UCB, Inc. | 8 | $139 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
Products named: DUPIXENT, Otezla, CIBINQO, RINVOQ, TREMFYA, SKYRIZI, TALTZ, ILUMYA.
Industry payments across CA — which companies pay providers there.
